3YY-23783-52284
4 vaccinations
6 coded responses
32 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 770 / TX
- Registered
- 2021-02-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
QX2-24413-44756
Child or adolescent in my care · Male · 2022-10-15
Timeline
-
2021-02-06
Dose 1 — Pfizer-BioNTech
-
2021-02-26
Registered in v-safe
- 2021-02-26
-
2021-02-27
Dose 2 — Pfizer-BioNTech
- 2021-02-27
-
2021-02-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-01
- 2021-03-02
-
2021-03-03
Survey response — days 1–6 daily, dose 2MedDRA: Breast feeding — Feeling: GoodFree text: Breastfeeding if that helps with your data collectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-04
- 2021-03-05
- 2021-03-06
- 2021-03-13
- 2021-03-20
- 2021-03-27
- 2021-04-03
- 2021-04-10
- 2021-05-29
- 2021-08-28
-
2021-11-12
Dose 3 — Pfizer-BioNTech
- 2022-02-27
-
2022-05-13
Survey response — 6 months, dose 3MedDRA: COVID-19, Nasopharyngitis, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Covid-19, allergies & coldMedDRA releases: 2024-11 · check-in free text available
-
2022-05-13
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-05-16
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-10-11
Dose 4 — Pfizer-BioNTech
-
2022-10-11
Health check-in — day 0, dose 4Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-10-12
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2022-10-13
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Redness · Fever · Headache, Fatigue or tiredness, Nausea, Vomiting, DiarrheaAdult check-in
- 2022-10-14
- 2022-10-15
- 2022-10-17
- 2022-10-18
- 2022-10-25
- 2022-11-01
-
2022-11-08
Survey response — day 28, dose 4MedDRA: Cough, Oropharyngeal pain, Upper-airway cough syndrome — Feeling: FairFree text: Sore throat, minor cough, post nasal dripMedDRA releases: 2024-11 · check-in free text available
-
2022-11-15
Survey response — day 35, dose 4MedDRA: Cough, Ear discomfort, Fatigue, Nasal congestion — Feeling: Fair · Be unable to work or attend schoolFree text: Cough, stuffy nose, fatigue, clogged earaMedDRA releases: 2024-11 · check-in free text available
- 2022-11-22
-
2023-01-10
Survey response — 3 months, dose 4MedDRA: Cough, Fatigue, Nasal congestion, Nasopharyngitis, Sneezing — Feeling: FairMedDRA releases: 2024-11
-
2023-04-11
Survey response — 6 months, dose 4MedDRA: Cough, Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-04-11
Report sent to call center — 6 months, dose 4Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2023-04-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-06 | Pfizer-BioNTech | |
| 2 | 2021-02-27 | Pfizer-BioNTech | |
| 3 | 2021-11-12 | Pfizer-BioNTech | No |
| 4 | 2022-10-11 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-05-13 | Successful 2022-05-16 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2023-04-11 | Unsuccessful |
Free text
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Breastfeeding if that helps with your data collection
Release 11 — 6 months, dose 3
Symptoms: Covid-19, allergies & cold
Release 12 — day 28, dose 4
Symptoms: Sore throat, minor cough, post nasal drip
Release 12 — day 35, dose 4
Symptoms: Cough, stuffy nose, fatigue, clogged eara
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Ear discomfort | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SD | Upper-airway cough syndrome | · | · | ✓ |
| SRO | Breast feeding | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release